From Models to Meaning: The Integrator Pharmacologist's Role in Advancing Health Equity Across the Drug Development Continuum

Rajesh Krishna

Open source

DOI
10.1002/cpt.70398
Published
2026-07-20
Container
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cpt.70398,
  title = {From Models to Meaning: The Integrator Pharmacologist's Role in Advancing Health Equity Across the Drug Development Continuum},
  author = {Rajesh Krishna},
  year = {2026},
  journal = {Clinical Pharmacology \& Therapeutics},
  doi = {10.1002/cpt.70398},
  url = {https://doi.org/10.1002/cpt.70398}
}

RIS

TY  - JOUR
TI  - From Models to Meaning: The Integrator Pharmacologist's Role in Advancing Health Equity Across the Drug Development Continuum
AU  - Rajesh Krishna
PY  - 2026
JO  - Clinical Pharmacology & Therapeutics
DO  - 10.1002/cpt.70398
UR  - https://doi.org/10.1002/cpt.70398
ER  - 

APA

Krishna, R. (2026). From Models to Meaning: The Integrator Pharmacologist's Role in Advancing Health Equity Across the Drug Development Continuum. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70398

Source records